Project Grant R03HD112688
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$162K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $802,762 to The University of Texas Southwestern Medical Center to investigate the genetic mechanisms underlying congenital heart disease (CHD). The key objectives are to: 1) Define the transcription factors and gene regulatory networks controlling human cardiac development; 2) Identify and characterize genetic variants regulating cardiac gene programs; and 3)...
This Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) will provide $315,999 to the Research Institute at Nationwide Children's Hospital to conduct research aimed at uncovering the role of incomplete penetrance genes in congenital heart disease (CHD). The key products and services to be delivered include: Sourcing a large cohort of CHD families from multiple data sources to perform a genetic association study and pedigree...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 Cardiovascular Diseases Research, will provide $267,000 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) from August 1, 2025 to July 31, 2027. The goal of this project is to identify shared genetic mechanisms that disrupt both heart and brain development in individuals with congenital heart disease (CHD) and neurodevelopmental delays (NDD). The...
This $876,314 Project Grant from the National Institutes of Health's National Institute of Child Health and Human Development Extramural Research program (CFDA 93.865) funds research at the University of North Texas on Notch signaling pathways related to hypoplastic left heart syndrome. The University will investigate the role of Notch1 signaling in vascular development of the heart using genome-edited induced pluripotent stem cell-derived vascularized cardiac organoids. Researchers aim to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $487,567 to Indiana University to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects (CHDs). The research aims to identify genetic variants and biological pathways associated with CHDs, as well as build predictive models leveraging genetic, epigenetic,...
This $701,842 Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support research at the University of South Florida to investigate the role of the CDK13 gene in the development of congenital heart defects. The project aims to utilize mouse models and human induced pluripotent stem cell-derived cardiomyocytes to better understand how mutations in CDK13 disrupt RNA processing and lead to cardiac...
This $506,984 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the role of the LRP1 gene in the development of congenital heart disease (CHD). The primary objectives are to: Examine the deployment and migration of cardiac neural crest cells (CNCCs) and their dependence on LRP1 using in vitro and in vivo cell lineage fate mapping analysis. Investigate the cellular and molecular...
This federal Project Grant award in the amount of $757,089 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports research to identify novel genes and genetic variants associated with congenital diaphragmatic hernia (CDH) and validate their role in mouse models. The awardee, Jackson Laboratory, will use genome data from a large CDH patient cohort to prioritize candidate genes and variants for validation in...
The federal Project Grant award R03HD113887, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the role of the ZFHX4 gene in lung mesenchyme development and its potential implications for understanding the pathogenesis of lung hypoplasia in congenital diaphragmatic hernia (CDH). The $164,990 award, with a performance period from August 1, 2024 to...
The National Institute of Child Health and Human Development (NICHD) awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $167,000 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to study the impact of epigenetic regulation on lung stem cells in congenital lung diseases. The project aims to determine how genetic variants and pharmaceutical interventions affect the differentiation and self-renewal of...